Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Elite Pharmaceuticals Inc. (ELTP) had Debt to Capital Ratio of 0.06 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$36.32M |
|
$13.70M |
|
$22.25M |
|
$14.07M |
|
$28.11M |
|
$8.21M |
|
$7.48M |
|
$15.69M |
|
$15.69M |
|
$13.70M |
|
$13.70M |
|
$13.70M |
|
$13.70M |
|
$8.21M |
|
$8.73M |
|
1.07B |
|
1.14B |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$85.79M |
|
$10.10M |
|
$31.45M |
|
$117.25M |
|
$10.67M |
|
$3.91M |
|
$44.99M |
|
$55.66M |
|
$61.59M |
|
$55.95M |
|
$61.59M |
|
1.07B |
|
| Cash Flow Statement Financials | |
$19.88M |
|
$-0.32M |
|
$-4.25M |
|
$11.77M |
|
$27.08M |
|
$15.31M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.04 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.06 |
0.07 |
|
38.75% |
|
22.61% |
|
22.61% |
|
-- |
|
43.20% |
|
37.73% |
|
$19.56M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
1.22 |
|
0.89 |
|
101.27 |
|
22.25% |
|
24.49% |
|
11.69% |
|
20.92% |
|
$0.06 |
|
$0.02 |
|
$0.02 |
|